To confirm the prognostic significance of FROUNT in other human cancers, we examined data from the PRECOG (166 studies), PrognoScan (86 studies) and HumanProteinAtlas (17 studies) human transcriptome databases, and studies selected based on the criteria of FDR q-values (the q-value is a measure of the strength of an observed statistic with respect to FDR20) < 0.05 revealed that the patients with higher expression of FROUNT exhibit a poorer prognosis (Supplementary Fig. 2a-c). Here, NUP85 is linked to cancer.